Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is underpriced on P/E.
Target Price
The average target price of SCIB.ST is 0.50 and suggests 87% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell